+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis



Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis



Chest 132(3): 959-965



Purpose: The aim of this study was to evaluate the usefulness of the whole-blood interferon-gamma assay (enzyme-linked immunosorbent assay [ELISA]) and interferon-gamma enzyme-linked immuno-spot assay (ELISPOT) based on early secretory antigenic target 6 and culture filtrate protein 10 in the diagnosis of active pulmonary tuberculosis (TB) in routine clinical practice. Method: We conducted a prospective study enrolling 144 participants with suspected pulmonary TB in a tertiary referral hospital in Seoul, South Korea, to investigate the diagnostic sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of these tests. Clinical assessment, tuberculin skin test (TST), whole-blood interferon-gamma ELISA (Quanti-FERON-TB Gold [QFT-G]; Cellestis Ltd; Victoria, Australia), and an ELISPOT assay (T SPOT.TB; Oxford Immunotec; Oxford, UK) were performed. Test results were compared with the final confirmed diagnoses. Results: Active pulmonary TB was diagnosed in 67 of 144 participants (47%). Sensitivities of QFT-G and T SPOT.TB for active pulmonary TB were 89% (95% confidence interval [CI], 79 to 96%) and 92% (95% Cl, 83 to 97%), respectively; and specificities were 49% (95% Cl, 37 to 61%) and 47% (95% Cl, 36 to 59%). NPVs of QFT-G (84%; 95% CI, 69 to 93%) and T SPOT.TB (S7%; 95% CI, 73 to 96%) were higher than that of TST (64%; 95% CI, 51 to 76%) [p = 0.001 and p < 0.001, respectively]. Conclusion: High NPVs of QFT-G and T SPOT.TB for the diagnosis of active TB suggest the supplementary role of these tests for the diagnostic exclusion of active TB, although the low PPV limits their usefulness in routine clinical practice in South Korea, where the prevalence of latent TB infection is considerable.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 022069411

Download citation: RISBibTeXText

PMID: 17505029

DOI: 10.1378/chest.06-2805


Related references

Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clinical and Diagnostic Laboratory Immunology 12(11): 1311-1316, 2005

Rapid diagnosis of active pulmonary tuberculosis in the elderly using enzyme-linked immunospot assay for interferon-gamma. Journal of the American Geriatrics Society 57(12): 2361-2362, 2009

Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clinical and Vaccine Immunology 16(6): 879-884, 2009

Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferon-gamma in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 53(4): 546-547, 2010

Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for interferon-gamma. Nephrology Dialysis Transplantation 24(8): 2605-6; Author Reply 2606-7, 2009

Diagnostic usefulness of enzyme-linked immunospot assay for interferon-gamma for tuberculosis in cancer patients. Scandinavian Journal of Infectious Diseases 42(11-12): 851-856, 2010

Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerging Infectious Diseases 13(4): 553-558, 2007

Enzyme-linked immunospot assay for interferon-gamma to support the diagnosis of tuberculosis in diabetic patients. Scandinavian Journal of Infectious Diseases 42(10): 752-756, 2010

Factors Contributing to False-Negative Enzyme-Linked Immunospot Assay for Interferon-Gamma Results in Active Tuberculosis. Clinical Laboratory 63(4): 773-779, 2017

Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis'. Diagnostic Microbiology and Infectious Disease 71(2): 139-143, 2011

Diagnostic performance of enzyme-linked immunospot assay and whole-blood interferon-γ assay for the diagnosis of extrapulmonary tuberculosis. Journal of Microbiology Immunology and Infection 44(5): 406-407, 2011

An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. Journal of Clinical Microbiology 44(6): 1944-1950, 2006

Use of Pleural Fluid Interferon-gamma Enzyme-linked Immunospot Assay in the Diagnosis of Pleural Tuberculosis. Acta Medica Indonesiana 48(1): 41-47, 2016

Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous pleurisy. Clinical Microbiology and Infection 15(2): 173-179, 2009

Diagnosis of peripheral tuberculous lymphadenitis by enzyme-linked immunospot assay for interferon-gamma. American Journal of Medicine 122(8): E3; Author Reply E5, 2009